The Daily News interviews Nir Barzilai, M.D., about the rise in senior citizens staying in the workforce into their 80s and 90s and his research into the longevity genes of SuperAgers, a group of healthy and active centenarians. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
April 30, 2012
The Associated Press interviews Nir Barzilai, M.D., about falsified University of Connecticut research on resveratrol, the red wine ingredient thought to improve health. Dr. Barzilai notes that the allegations will have no impact on resveratrol research because encouraging results have emerged from numerous labs around the world, including Einstein’s. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
January 13, 2012
CBS’ The Early Show interviews Nir Barzilai, M.D., about his genetics research into exceptional longevity in a segment featuring Longevity Genes Project study participant and world’s oldest stock broker Irving Kahn (age 105). Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
December 14, 2011
The Forward has named Nir Barzilai, M.D., to “The Forward 50,” the magazine’s annual list of those who have made a significant impact on the Jewish story in the past year. Dr. Barzilai, who was recently featured in a cover story in New York magazine, was highlighted in The Forward for his longevity research at Einstein and leadership role in the centenarian consortium for the $10 million Archon Genomics X Prize competition. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
November 17, 2011
New York magazine interviews Nir Barzilai, M.D., and Gil Atzmon, Ph.D., for a cover story on exceptional aging that centers on Irving Kahn (age 105) and his siblings, all participants in Einstein’s Longevity Genes Project. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research. Dr. Atzmon is assistant professor of medicine and of genetics.
November 7, 2011
USA Today (via HealthDay) interviews Nir Barzilai, M.D., about a new study that showed removing "senescent" cells – aging cells that do not function properly and disrupt surrounding healthy tissues – reduced or even eliminated age-related diseases in mice. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
November 3, 2011
Associated Press interviews Nir Barzilai, M.D., about his longevity research and the Archon Genomics X PRIZE, a $10 million dollar competition that challenges teams to sequence the complete genomes of healthy centenarians, some of which will come from Dr. Barzilai’s Longevity Genes Project. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
October 26, 2011
WSJ.com interviews Nir Barzilai, M.D., about his ongoing research with more than 500 centenarians, some whose unhealthy habits – including smoking and overeating – seem to have no impact on their longevity. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of both the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging. For more on Dr. Barzilai's research, visit www.SuperAgers.com.
July 13, 2011
The Wall Street Journal interviews Nir Barzilai, M.D., for an article on financial planning for individuals expected to live into their 90s. While the article details some investment and insurance options designed to cover the increased costs of living longer, Dr. Barzilai notes that the final healthcare costs for centenarians are typically about one-third of those costs for someone who dies at 67. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
June 20, 2011
Seattle NPR station KUOW interviews Nir Barzilai, M.D., and Ana Maria Cuervo, M.D., Ph.D., about the biology of aging and the genetics of longevity. Dr. Cuervo discussed autophagy, the process of cell regulation, and the role it plays in keeping organs young, potentially leading to longer life spans. Dr. Barzilai discussed his genetic research with centenarians and the importance of discovering the key to healthy aging. Dr. Cuervo is professor of developmental and molecular biology. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
April 8, 2011
Reuters Health interviews Nir Barzilai, M.D., about a new study showing that men who reach the age of 85 tended to have high levels of good cholesterol (HDL) – over 50 milligrams per deciliter (mg/dL) – while in their 60s. Dr. Barzilai notes that while exercise may raise a person’s HDL a few points, there are drugs currently in development which may raise it more substantially. Whether or not they would actually improve healthy aging remains to be seen. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging.
February 24, 2011
PBS NewsHour's The Rundown blog interviews Nir Barzilai, M.D., about a new study indicating that a dwarfism gene may provide protection against diabetes, cancer and other age-related diseases. The study focuses on a family in Ecuador whose members carry a gene that prevents the body from using growth hormone, a condition that leads to dwarfism. Dr. Barzilai notes that in nature, dwarf models live longer — small dogs live longer than large dogs, ponies longer than horses — and that this study represents an important finding in aging research. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging.
More coverage on this story
Los Angeles Times
February 17, 2011
NOVA scienceNow interviews Nir Barzilai, M.D., about his research on more than 500 centenarians in a segment on the FOXO gene and its role in aging. He notes that the FOXO gene has been linked to longevity in multiple studies. The segment also includes interviews with several of the participants in Dr. Barziali's ongoing longevity study. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging (interview begins 9 minutes into the segment). For more on Dr. Barzilai's research, visit www.SuperAgers.com
January 27, 2011
The New York Daily News interviews Nir Barzilai, M.D., and researcher William Greiner, R.N., M.S., regarding the Longevity Genes Project, a genetics study of 500 centenarians, about the role genes play in longevity. Dr. Barzilai notes that the centenarians in the study seem to have genetic traits that delay age-related diseases. The story also profiles several of the participants in the Longevity Genes Project and highlights SuperAgers.com, a new website about the study. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of both the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging.
More coverage on this story
Huffington Post
Crain's New York
Jewish Week
November 22, 2010